Nanoparticle-Based Therapeutic Strategies Targeting Major Clinical Challenges in Pancreatic Cancer Treatment

The authors focus on the pathological hallmarks of PDAC and the impact of nanotechnology to find solutions, describing the use of nanoparticle-based systems designed for the delivery of chemotherapeutic agents and combinatorial alternatives that address the chemoresistance associated with PDAC.